The global cell separation market size is expected to reach USD 17.43 billion by 2030, registering a CAGR of 9.94% over the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth. The key players focus on the development & commercialization of advanced products to cater to the needs of researchers and healthcare professionals, which is projected to drive the demand for cell isolation products in the near future.The usage of cellular therapies is increasing for the treatment of prominent diseases, including neurological diseases, such as amyotrophic lateral sclerosis, Parkinson’s disease, spinal cord injury, and renal, skeletal, & autoimmune diseases, such as multiple sclerosis, type 1 diabetes, & Crohn's disease.
In recent years, there has been an increase in funding from government organizations for cell-based research owing to its ability to treat & manage conditions, such as cancer and other chronic diseases. The global market witnessed an upward momentum during the pandemic. For instance, in 2020, Seattle Children's Research Institute's researchers used immunoprecipitation, identified by flow cytometry (IP-FCM) test, to study the immune response of COVID-19-infected patients. As per the experiment, blood samples were collected from 24 COVID-19-positive patients to compare with blood samples of 30 healthy individuals, and the compared samples were run through the IP-FCM test.Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.
Request a free sample copy or view report summary: Cell Separation Market Report
The consumables product type segment held a major revenue share of 61.94% in 2023. The increasing investments in R&D by biopharmaceutical and biotech companies are a major factor propelling the segment growth
The biomolecule isolation application segment held the largest share of 29.5% in 2023 since it is a pivotal step in research on cancer, HIV, and other autoimmune diseases
The human cell type segment is anticipated to have a significant growth rate of 12.47% during the forecast period. The fast growth is due to the rising focus on human and cancer stem cell research and varied applications of isolated human cells
The centrifugation technique type segment held the highest market share of 42.3% in 2023. The availability of various centrifuges provides technicians with a wide range of options catering to their specific needs
North America dominated the global market with a revenue share of 39.8% in 2023 owing to increasing demand for new technologies, a large pool of key players, increasing development of vaccines and therapeutics, along with advanced healthcare infrastructure
Grand View Research has segmented the global product lifecycle management market based on product, cell type,technique,application, end-use, and region:
Cell Separation Product Outlook (Revenue, USD Million, 2018 - 2030)
Consumables
Reagents, Kits, Media, and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Filtration Systems
Magnetic-activated Cell Separator Systems
Cell Separation Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
Human Cells
Animal Cells
Cell Separation Technique Outlook (Revenue, USD Million, 2018 - 2030)
Centrifugation
Surface Marker
Filtration
Cell Separation Application Outlook (Revenue, USD Million, 2018 - 2030)
Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration
In Vitro Diagnostics
Therapeutics
Cell Separation End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Research laboratories and institutes
Biotechnology and biopharmaceutical companies
Hospitals and diagnostic laboratories
Cell banks
Cell Separation Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Russia
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Cell Separation Market
Thermo Fisher Scientific, Inc.
BD
Danaher
Terumo Corp.
STEMCELL Technologies Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
Corning Inc.
Akadeum Life Sciences
"The quality of research they have done for us has been excellent..."